RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Capital expenditures

RESMED INC【RMD】

Market cap
$37B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Jun 30, 2025-90-9.65%
Jun 30, 2024-99-16.89%
Jun 30, 2023-120-11.25%
Jun 30, 2022-135+31.27%
Jun 30, 2021-103+7.74%
Jun 30, 2020-95+38.74%
Jun 30, 2019-69+9.79%
Jun 30, 2018-63+0.58%
Jun 30, 2017-62+6.30%
Jun 30, 2016-59-6.35%
Jun 30, 2015-63-14.05%
Jun 30, 2014-73+14.38%
Jun 30, 2013-64+34.89%
Jun 30, 2012-47-29.24%
Jun 30, 2011-67

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)